A small increase in the risk of infections has been reported in patients treated with bevacizumab, but HHT may also predispose to an increased risk of infections, given the reported involvement of endoglin in macrophage migration processes through the endothelium in proinflammatory states [36]. This evidence concerns the gene ENG and infection.